Lyrica Generics Were Likely Delayed By A Pfizer Labeling Supplement

 
• By Derrick Gingery

US FDA's last-minute approval may have allowed Pfizer three more weeks of sales without competition.

stopping the Dominio effect
A labeling update approved just before patent expiry may have caused Lyrica generics to be cleared later than expected in the US • Source: Shutterstock

More from Regulation

More from Policy & Regulation